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Predicting disease incidence based on Single Nucleotide Polymorphisms (SNPs) for a 
complex multi-factorial disease like sarcoidosis remains a difficult prediction problem. If 
disease prediction could be improved, genetic screening could be implemented to assist 
identifying disease early, potentially improving patient outcomes.  
In this thesis, we examine the predictive performance of several supervised machine 
learning models to assess if genetic variability can be used to accurately predict disease 
incidence in an African American patient population (n = 2,915). Further, we consider 
the use of SNP “functional scores” such as Combined Annotation Dependent Deletion 
(CADD) scores and FATHMM-XF scores to see if they can improve predictive ability. 
Here we show that support vector machine (SVM), and random forest (RF) models can 
significantly outperform the naïve baseline model (p < 0.05) in terms of accuracy and 
achieve area under the ROC curve (AUC) values of 0.6016 and 0.6019, respectively. A 
neural network (NN) model had the optimal AUC value of 0.6103 but was slightly non-
significant (p = 0.05) when compared to the naïve model in terms of accuracy. The 
overall impact of adding functional scores was minimal to negative on predictive 
performance. 
This work reveals that supervised machine learning based on SNPs can significantly 
outperform random chance when predicting sarcoidosis incidence and supports the idea 
that genetic screening and disease modeling prior to disease incidence could improve 
preventative care.  
 
 
Keywords: Supervised Machine Learning, Disease Prediction, Single Nucleotide 
Polymorphisms (SNPs), Sarcoidosis, Disease Modeling, Random Forest, Support 
Vector Machine (SVM), Neural Network  
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Chapter 1 – Introduction 
 
1.1 - Predicting disease is a key challenge that can be aided by machine 
learning 
 
Predicting disease incidence prior to symptom presentation is a key challenge in 
modern medicine, as achieving highly accurate disease predictions could lead to earlier 
detection of initial disease, which has potential to improve patient outcomes. For 
example, clinicians routinely screen patients deemed at high risk for colorectal cancer 
due to family history or prior disease, which has been shown to save countless lives due 
to early detection (Kahi et al., 2018). However, over-screening patients for suspected 
disease when none is present could burden patients with unnecessary cost, invasive 
screening procedures, psychological stress, false positives, and could potentially initiate 
the “nocebo” effect (Colloca & Miller, 2011), triggering negative symptoms despite 
absence of disease. It is imperative therefore that any disease prediction or risk 
assessment method be highly accurate prior to implementation in the clinic. Due to the 
benefits of early disease detection and the risks of inaccurate prediction, novel methods 
of identifying patients at high risk for life-threatening diseases should be explored and 
optimized to maximize accuracy. 
One such method to identify people at high risk for disease is calculating a 
weighted polygenic risk score (Ho et al., 2019; Polygenic Risk Scores, 2020). This 
approach sums the number of individual risk alleles the person carries, weighted by how 
strongly each risk allele associates with disease in a genome-wide association study 
(GWAS), to generate a score which describes the patient’s relative risk of developing a 
specific disease. This approach is attractive because it does not require a person to be 
sick or have a family history to assess disease risk. Additionally, it only requires a 
simple blood draw, DNA extraction, and a genotyping assay, which is becoming 
increasingly inexpensive (Li et al., 2008). However, polygenic risk scores have received 
criticism for being unable to model complex interactions which occur in many diseases 
(Ho et al., 2019), overly training on European ancestry patients which limits their utility 
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in other populations (De La Vega & Bustamante, 2018), and achieving only moderate 
accuracy in predicting disease outcome for several diseases (Belsky et al., 2013; Lewis 
& Vassos, 2020). 
An alternative approach is to utilize supervised machine learning algorithms 
trained on a large cohort of case and control patients, using the most disease-
associated patient single nucleotide polymorphisms (SNPs) identified by GWAS to 
generate a predictive model (Ho et al., 2019). This approach shares the advantages of 
polygenic risk scores yet produces more complex models capable of identifying 
otherwise unseen structure in the data, which has been shown to improve disease 
prediction accuracy compared to polygenic risk scores alone (Joseph et al., 2018; 
Kruppa et al., 2012; Paré et al., 2017). This approach still suffers from relying on data 
from predominately individuals with European ancestry, which limits utility in non-
European populations, as well as demands a large amount of high-quality genotyped 
case and control data to effectively train the model. 
 
1.2 - Hypothesis 1 – Machine learning can classify sarcoidosis cases with 
better than random chance 
 
We hypothesized that machine learning could be useful in improving our ability to 
predict sarcoidosis disease incidence. Sarcoidosis is a complex disease with both 
genetic and environmental components contributing to pathology (Moller et al., 2017) 
and can be life-threatening in severe cases (Baughman & Lower, 2011). Additionally, 
accurately diagnosing sarcoidosis remains challenging due to minimal signs and 
symptoms in early stages of disease as well as similarity of symptoms to other common 
diseases (Sarcoidosis - Diagnosis and Treatment - Mayo Clinic, 2019). The defining 
feature of sarcoidosis is formation of clusters of inflammatory cells called granulomas, 
which typically form in the lungs but can also be found in other organs (Learn About 
Sarcoidosis - American Lung Association, 2020). However, several other diseases also 
feature granulomas, such as Crohn’s disease (Molnár et al., 2005), rheumatoid arthritis 
(Imadojemu et al., 2016), and tuberculosis (Silva Miranda et al., 2012), among others. A 
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battery of tests is typically required to confirm sarcoidosis and rule out other disorders, 
such as chest X-ray, computerized tomography (CT), pulmonary function tests, and 
invasive lung or skin biopsy to collect granuloma samples (Sarcoidosis - Diagnosis and 
Treatment - Mayo Clinic, 2019). The difficulty of diagnosis underscores the need for 
robust genetic prediction tools to aid in identifying high-risk patients. 
The etiology of sarcoidosis is currently unknown, but it is widely believed that 
environmental pollutants and/or bacterial or fungal infection triggers the onset of 
granulomatous formations, then the autoimmune system fails to resolve the granulomas 
once the pollutant or bacteria is cleared (Starshinova et al., 2020). Mycobacterium 
species may play a role, as well as working in environments with high mold/mildew, or 
exposure to some inorganic aerosols such as insecticides, certain metals, or wood 
smoke and ash (Judson, 2020; Moller et al., 2017). 
 Due to the combination of genetic and environmental contributions to sarcoidosis 
pathology, there is a theoretical limit to the performance of any genetics-only approach 
to predicting disease incidence. According to one study of 210 Danish and Finnish twin 
pairs, the heritable component of sarcoidosis was calculated to be 66% (95% C.I. 0.45 
to 0.8) (Sverrild et al., 2008). A Swedish familial aggregation study looking at 23,888 
cases and 171,891 general-population controls estimated the heritability to be 39% 
(95% C.I. 0.12 to 0.65) (Rossides et al., 2018). Both studies reach the conclusion that 
genetics plays a significant but non-exclusive role in sarcoidosis disease incidence. An 
optimal model therefore would require using “blended” data types, including both 
genetics, and known environmental exposures to disease-associated pollutants and/or 
pathogens.  
Construction of this ideal “blended” dataset remains challenging, due to lack of 
knowledge about which specific pollutants contribute most to disease combined with the 
impracticality or impossibility of quantitatively measuring how much exposure a person 
has had to a particular pollutant such as wood smoke or aerosolized metal. Qualitative 
assessment of known exposure to a given pollutant could be obtained via questionnaire 
(e.g., asking a person how often they are around wood burning stoves or fires), which 
may still contain predictive value and improve modeling performance in combination 
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with genotyping data. Incorporating gene-environment interaction in predictive models 
has been shown to improve phenotype predictive performance in yeast and plants 
(Grinberg et al., 2020) as well as Parkinson’s disease prediction (Jacobs et al., 2020); 
however, a robust dataset of this type has not been created for sarcoidosis to our 
knowledge. 
 Despite the limitations of implementing a genetics-only approach to model 
disease incidence of sarcoidosis, we attempted to obtain model sensitivity near the 
estimated heritability of ~40% using a dataset of 2,915 genotyped African American 
sarcoidosis patients and controls with supervised machine learning. We first utilized 
genome-wide association (GWA) to identify the most correlated SNPs with disease, 
then used these top SNPs as features to build three classifiers based on random forest 
(RF), support vector machine (SVM), and neural network (NN). We then evaluated the 
performance of the models on unseen test data [See Chapter 2.2– Data Preparation]. 
The best model’s most important features were identified and could be used to inform 
future studies or experiments. However, simply because a SNP is considered useful for 
classification does not necessarily mean that SNP plays an important biological role in 
disease incidence. The individual SNP in question may be in Linkage Disequilibrium 
(LD) with a nearby SNPs that plays a more causal role, it may be useful for 
classification by random chance, or it may be interacting with another important SNP 
which has a more causal role. 
 
1.3 - Determining if single nucleotide polymorphisms have functional 
consequences or if they are benign is an active area of research 
 
 Assessing if a SNP has a functional role in forming a person’s phenotype is an 
active area of research, both experimentally and computationally. Over 335 million 
SNPs have been identified from humans across the globe and a single individual 
contains around 4 to 5 million differences compared to the reference genome (Auton et 
al., 2015). Understanding which of these SNPs play functional roles in determining 
human traits or disease and which are inconsequential is an ongoing scientific effort. 
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Projects such as the Encyclopedia of DNA Elements (ENCODE), the Roadmap 
Epigenomics Project, RegulomeDB, and HaploReg aim to help address this large 
challenge (Abascal et al., 2020; Boyle et al., 2012; Roadmap Epigenomics Consortium 
et al., 2015; Ward & Kellis, 2016). 
Determining functional consequences of SNPs in protein-coding regions, while 
still challenging, is more straightforward than non-coding SNPs, because changes to 
protein-coding regions of a genome can result in predictable changes to amino acid 
sequence based on the standard genetic codon table. If an early stop codon is 
introduced for example, entire proteins or chunks of proteins can be lost, leading to 
diseases such as Duchenne muscular dystrophy and cystic fibrosis (Keeling et al., 
2013). A compendium of known inherited genetic disorders based on changes to protein 
coding sequences, known as the Online Mendelian Inheritance in Man (OMIM) was 
created and is maintained to assist in identifying which disorders (phenotypes) are 
generated from which specific changes to protein coding sequences (Amberger et al., 
2019).  
In general, phenotypic characterization of amino acid changes due to SNPs still 
requires experimental and/or observational validation, because predicting function 
involves predicting protein folding, then predicting protein-protein interactions, then 
predicting how those altered interactions will affect the rest of the organism’s biology, 
which remains an immensely challenging task. Great strides have been made recently 
to improve protein folding predictions using deep learning (Senior et al., 2020). Still, the 
challenge of in silico predicting phenotypic changes based on changes to protein coding 
regions remains standing. 
The problem of predicting functional effects is compounded when non-protein 
coding SNPs are considered. Most SNPs occur outside the protein-coding regions of 
the genome, primarily due to increased selection pressure on the coding regions 
compared to the non-coding regions (Barreiro et al., 2008). Areas of the non-coding 
regions can still play vital regulatory roles by enabling transcription factor or promoter or 
silencer binding, acting as a cis- or trans-regulatory elements, being involved in 
epigenetic regulation, or regulating telomeres (Carroll, 2008; Cusanelli & Chartrand, 
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2014; Kasowski et al., 2010). Other areas of the non-coding region may have lost their 
function entirely and thus carry no evolutionary consequences when mutations occur in 
these regions, leading to accumulation of SNPs without functional effects (Zheng et al., 
2007). Due to this variability across the non-coding regions of the genome, it is unclear 
if a given SNP will have a functional consequence or not simply based on nucleotide 
change alone. Additional context, such as adjacency to a coding region, location in 
known regulatory regions, or experimental modification in cell or tissue culture, is 
required to estimate the likelihood of a SNP’s potential to have a functional effect. 
Several machine learning efforts have been conducted to classify each known 
SNP as either functional or non-functional. One such effort has been the generation of 
Combined Annotation Dependent Depletion (CADD) scores (Kircher et al., 2014). In this 
study, researchers trained a support vector machine (SVM) to differentiate between 
14.7 million high-frequency human alleles versus 14.7 million simulated variants using a 
suite of over 60 different features as predictors. Some features used include 
measurements of evolutionary conservation, open chromatin, acetylation or methylation, 
distance from the nearest transcription factor binding site, human genetic frequency, 
along with many more. The logic behind comparing actual observed high-frequency 
alleles with simulated alleles is that deleterious mutations that reduce an organism’s 
fitness tend to decrease over time due to natural selection, but these deleterious 
mutations will not be reduced in the simulation. The CADD-score, or “C-score,” 
therefore measures how likely a given SNP is to be deleterious to an organism’s fitness. 
This measurement correlates with changes in both molecular functionality and 
pathogenicity of a particular SNP. The researchers applied their trained model to 
generate C-scores for every human SNPs and have continued to update their scores for 
the latest version of the GRCh38 genome assembly (Rentzsch et al., 2019). One 
limitation of this approach is that disease-causing SNPs can survive natural selection if 
they cause disease in middle or old age, past the point of reproductive pressure. 
Another approach that has been attempted to assess the deleteriousness of a 
specific SNPs is called FATHMM-MKL (Shihab et al., 2015). This approach leverages a 
manually curated database of known, heritable, disease-causing variants, the Human 
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Gene Mutation Database (Stenson et al., 2017), to generate a robust list of deleterious 
SNPs that are known to cause disease. They then generated a list of SNPs unlikely to 
cause disease by pulling SNPs from the 1000 genomes project (Altshuler et al., 2012) 
which were presumed to be benign due to their absence in the Gene Mutation 
Database. The features they used to train this model included: vertebrate sequence 
conservation, histone modification, transcription factor binding sites, open chromatin, 
local GC content 5bp around the SNP, and more. They trained their model using SVM 
with multiple kernel learning, and demonstrated superior performance compared to 
CADD on unbiased test samples. In early 2018, an updated model called FATHMM-XF 
was published, improving the results from FATHMM-MKL by utilizing additional features 
during model training (Rogers et al., 2018). Prediction scores are available for all 
GRCh37 and GRCh38 SNPs . 
A meta-analysis conducted in 2018, prior to the release of FATHMM-XF, 
compared 15 different genome-wide deleterious prediction scores and 8 conservation 
scores to evaluate which models perform the best when predicting non-coding 
deleteriousness and found that the FATHMM-MKL model outperformed the competition 
(Liu et al., 2017). However, this result is perhaps biased toward FATHMM-MKL 
compared to CADD because the test samples used in the meta-analysis were pulled 
from the Human Gene Mutation Database. Nonetheless, in silico functional 
characterization of SNPs has demonstrated remarkable accuracy in predicting variants 
likely to cause deleterious effects in humans, and hopefully can be leveraged to 
potentially improve sarcoidosis modeling accuracy. 
 
1.4 - Hypothesis 2 – Incorporating functional scores can improve 
sarcoidosis disease incidence predictive accuracy 
 
Since sarcoidosis has a strong heritability component (~40-66%), some disease-
causing variants must also be heritable and therefore might be identifiable via 
FATHMM-XF scores or C-scores. We hypothesized that incorporating functional 
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prediction scores into our sarcoidosis prediction model would improve prediction 
accuracy, specifically by helping to identify and prioritize causal variants over variants 
that are associated with disease simply by chance or simply by being passengers in LD 
with the causal variants. This approach also has the advantage of generating novel lists 
of SNPs that can be used to investigate mechanisms of disease incidence in future 
studies. We generated a single “blended” association plus pathogenicity score, which 
rewards a SNP for being highly correlated with disease as well as having a high C-score 





















Chapter 2 – Data Preparation 
 
2.1 - Code Availability 
 
All R code, Bash shell commands, and trained model files used in this project are 
available at: https://github.com/cejdan/sarc-predictions  
 
2.2 - Data Preparation and Quality Control 
 
 2,918 African American patient samples were obtained as part of the ACCESS 
sarcoidosis study (Freemer & King, 2001), the SAGA sarcoidosis study (Rybicki et al., 
2005), or the Henry Ford Health System (HFHS) and were genotyped. More details on 
sample collection and genotyping can be found in previous work (Adrianto et al., 2012).   
Nucleotides not captured by the original sequencing arrays were imputed with the 
TOPmed imputation server (Taliun et al., 2021) using the following settings: r2 
reference panel, GRCh38 reference build, no R-squared filter, and Eagle v2.4 phasing. 
TOPmed imputations were then quality controlled to remove any SNPs that were in high 
linkage disequilibrium with other SNPs (defined as r-squared < 0.5). Next, we replaced 
imputed nucleotides with observed nucleotides when available. This data set contained 
2,918 individuals from 1,969 unique families, 819 males and 2,099 females, 1,273 
cases and 1,645 controls, and 69,887,691 SNP variants.  
 The following quality controls were then used to filter and clean the data to make 
it more suitable for GWAS and subsequent modeling:  
1) Remove any individuals with < 90% genotyping rate (10% missing rate).  
2) Remove SNPs that have any missing values for any individual. This step helps 
simplify downstream modeling by ensuring all data is free of missing values.  
3) Remove minor alleles with < 1% frequency.  
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4) Remove variants that reach 0.0001 significance on the Hardy-Weinberg equilibrium 
test.  
5) Remove individuals that have more than 5% Mendelian errors. 
After quality control, the remaining dataset contained 2,915 individuals from 1,969 
unique families, 818 males and 2,097 females, 1,272 cases and 1,643 controls, and  
7,723,467 SNP variants. 
2.3 - Creation of Test and Training data subsets 
 
 Prior to any modeling, we separated test and training datasets to ensure 
independence of samples. Careful consideration had to be taken during this step to 
ensure that whole families were kept entirely within either the training set or the test set, 
as family members present in both training and test sets would reduce the 
independence of the test set.  
To accomplish this, we randomly sampled the quality-controlled data based on 
family ID, not individual ID. We also wanted to maintain similar ratio of cases and 
controls in both training and test sets. We randomly sampled ~10% of the 935 families 
containing at least one member with sarcoidosis (94 families sampled of the 935) as 
well as ~10% of the 1,367 families containing at least one member as a control (137 
families sampled out of 1367 families), which left us 231 families in the test set. 
However, 4 of these families were sampled twice by random chance and were dropped 
from the test set, which left 227 families in the test set. In total, 412 individuals (229 
controls and 183 cases) from 227 families were used as the test set (55.6% controls, 
44.4% cases), while 2,503 (1,414 controls and 1,089 cases) from 1742 families were 
used as the training set (56.5% controls, 43.5% cases). No families were separated. 
New training-specific and test-specific binary plink files were generated to ensure that 




2.4 - Principle Component Analysis, Logistic regression, and LASSO 
regression 
 
 We performed principal component analysis (PCA) on the training samples to 
help adjust for correlated ancestry during the logistic regression step and used the first 
4 PCs as covariates in the model. It is common practice in GWA studies to account for 
correlated ancestry by using PCs as covariates in your model, as it improves the 
robustness of the results (C. Chen, 2019).  
 Next, to help narrow the list of SNPs down from 7.7 million, we performed logistic 
regression using Plink v1.9 (Chang et al., 2015) to generate odds ratios and p-values 




Figure 1. Manhattan plot of the training samples GWAS. Blue line at p = 1x10-5 indicates 
genome-wide suggestive SNPs. Red line at p = 5x10-8 indicates genome-wide 
significant SNPs. The large number genome-wide significant SNPs on chromosome 6 
correspond to the major histocompatibility complex (MHC) region of the genome, which 
is highly variable and involved in antigen presentation. SNPs ranked below p > 1x10-3  
were omitted from the plot for clarity. 
 
The resulting Manhattan plot displayed similar significant SNPs to those previously 
published (Adrianto et al., 2012). The main advantage of performing the logistic 
regression was that we were able to obtain a list of the most highly linearly correlated 
SNPs with the disease. In essence, this analysis was feature selection, helping to 
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narrow our initial list of 7.7 million features down to only the top features expected to 
contribute to predictive modeling. We did not limit ourselves to using only the genome-
wide significant SNPs while modeling, because one major advantage of using machine 
learning to model disease incidence is that using SNPs with smaller effect sizes can still 
improve performance.  
 After performing logistic regression, we also performed a least absolute 
shrinkage and selection operator (LASSO) regression, which performs an L1 
regularization, a linear modeling technique that reduces the effect sizes of unimportant 
features down to zero while keeping features with non-zero effect sizes. (Tibshirani, 
1996). This approach offered an alternative way to prioritize SNPs. After performing 
LASSO, we had 484 SNPs with non-zero effect sizes remaining. 
 
2.5 - Preparation for modeling and exploratory data analysis 
 
 After sorting the logistic regression results by p-value, we extracted the top 10 
SNPs, top 100 SNPs, top 500 SNPs, top 1000 SNPs, and top 2000 SNPs. Using Plink 
v1.9, we then extracted the total number of minor alleles carried by each patient at each 
SNP, generating a matrix defined by: 
𝑀𝑀𝑖𝑖,𝑗𝑗 =  �
      0    𝑖𝑖𝑖𝑖 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑖𝑖 ℎ𝑎𝑎𝑝𝑝 𝑝𝑝𝑝𝑝 𝑚𝑚𝑖𝑖𝑝𝑝𝑝𝑝𝑝𝑝 𝑎𝑎𝑎𝑎𝑎𝑎𝑝𝑝𝑎𝑎𝑝𝑝𝑝𝑝 𝑎𝑎𝑎𝑎 𝑆𝑆𝑆𝑆𝑆𝑆 𝑗𝑗 
  1    𝑖𝑖𝑖𝑖 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑖𝑖 ℎ𝑎𝑎𝑝𝑝 1 𝑚𝑚𝑖𝑖𝑝𝑝𝑝𝑝𝑝𝑝 𝑎𝑎𝑎𝑎𝑎𝑎𝑝𝑝𝑎𝑎𝑝𝑝𝑝𝑝 𝑎𝑎𝑎𝑎 𝑆𝑆𝑆𝑆𝑆𝑆 𝑗𝑗
2    𝑖𝑖𝑖𝑖 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 ℎ𝑎𝑎𝑝𝑝 2 𝑚𝑚𝑖𝑖𝑝𝑝𝑝𝑝𝑝𝑝 𝑎𝑎𝑎𝑎𝑎𝑎𝑝𝑝𝑎𝑎𝑝𝑝𝑝𝑝 𝑎𝑎𝑎𝑎 𝑆𝑆𝑆𝑆𝑆𝑆 𝑗𝑗
 
In addition, the individual’s sex (based on XX or XY genotype) was added as a feature 
to the model, and the phenotype (class) column was added so that we could perform 
supervised machine learning. This matrix contained the raw data used for modeling. 
Some data cleaning was necessary prior to modeling because many of the features 
were very highly correlated due to linkage disequilibrium (LD) and thus contained 
redundant information. LD occurs because genetic recombination, the process of mixing 
an organism’s alleles during meiosis, occurs with decreasing probability the closer two 
sections of DNA are in the genome. Nearby SNPs on the same chromosome are 
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unlikely to have recombination occur between them, so they will usually be inherited as 
a unit. In our list of top 10 SNPs, almost all were SNPs on Chromosome 6 in proximity, 
and therefore high LD, with each other (Figure 2). In the case of the top 100 SNP 
correlation matrix, we find that large blocks of SNPs have high correlation coefficients 
within the block (Figure 3). These are known as haplotype blocks, sections of DNA that 
are often inherited together due to LD (Zhu et al., 2004).  
 
 
Figure 2. Pearson’s r2 correlation matrix of the top 10 SNPs extracted from the logistic 
regression model. Dark blue circles indicate that all SNPs have near-perfect correlations 






Figure 3. Pearson’s r2 correlation matrix of the top 100 SNPs (only top 50 SNPs are 
shown here for clarity). Large “blocks” of SNPs tend to be highly correlated as they are 
in close proximity to each other in the genome and thus are inherited together. These 
are known as haplotype blocks and contain large sections of redundant information that 
is not useful for downstream modeling. 
 
2.6 - Removal of correlated features 
 
To remove redundant information and improve model performance, the most 
highly correlated variables needed to be removed. To address this issue for the logistic 
regression models, we utilized the findCorrelation method in the caret package (Kuhn, 
2008) to eliminate correlated variables. This function works by checking each pairwise 
correlation value, and if the value is above a specified r2 threshold, the column with the 
higher mean correlation across all rows is selected for elimination. Several models were 
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trained with differing correlation values (0.75, 0.8, 0.85, 0.9, 0.95) to find the optimal 
correlation removal threshold (see Chapter 2 – Random Forest modeling). An example 
using an r2 cutoff of 0.95 on the top 100 SNPs is shown (Figure 4). The number of 
features retained for each subset of the initial data matrix across the different correlation 
cutoffs is described in Table 1.  
For the LASSO model, SNPs were eliminated by comparing each pairwise 
Pearson r2 value and eliminating the column with the lower absolute value effect size. 
This was done to preserve the maximum amount of useful information in the final 
model. The SNPs retained for each Pearson r2 threshold cutoff for the LASSO model is 
also summarized in Table 1. In general, fewer SNPs were eliminated from the LASSO 
model because the L1 regularization process reduces effect sizes to zero or near-zero 





Figure 4. Top 100 SNP correlation matrix with Pearson r2 correlations > 0.95 removed. 
18 SNPs survive this cutoff and are shown here. Most of the highly correlated haplotype 
blocks are removed or reduced. 
 
Number of SNPs retained ≤0.75 ≤0.8 ≤0.85 ≤0.9 ≤0.95 
Logistic Top10 SNPs 1 1 1 1 1 
Logistic Top100 SNPs 10 12 12 16 18 
Logistic Top500 SNPs 69 78 90 104 114 
Logistic Top1000 SNPs 171 180 197 221 248 
Logistic Top2000 SNPs 451 469 507 558 625 
LASSO 484 SNPs 430 431 433 437 441 
Table 1. Number of SNPs retained for each “Top SNP” subset for various Pearson’s r2 




Chapter 3 – Random Forest, SVM, and Neural 
Network modeling 
 
3.1 - Random Forest Modeling – Background 
 
 After correlation removal, we could now begin addressing if machine learning 
could accurately predict sarcoidosis. We began by utilizing random forests (RFs) to 
construct the initial predictive models because RFs have been shown to be robust for 
learning structure in a variety of contexts, including genetics-based disease prediction 
for diseases like Type 2 Diabetes (López et al., 2018).  
RFs are composed of numerous binary decision trees. The individual trees are 
generally constructed using the Classification and Regression Tree (CART) 
methodology, whereby splits are created based on maximizing “information gain”, or 
maximum improvement to a given impurity index, usually the Gini Index. (Breiman et al., 
1984). In a CART decision tree, the initial node begins with all data from both classes 
present. We generate a split using one of the data’s columns based on the column that 
provides the maximum information gain, and the data is broken into two pieces, with the 
goal being to concentrate observations from class “A” on one side, and class “B” on the 
other. The more homogenous the class mixture in the new data, the “purer” the node is. 
The algorithm is repeated recursively, until all nodes reach a desired purity or until the 
tree reaches a desired depth or until there are no additional ways to separate the 
classes. If the tree grows to complete purity, all leaf nodes will contain data belonging to 
only a single class, but the tree may become very deep and complex. An example of a 







Figure 5. Simple binary decision tree using a single SNP, 6:32607969_G. The labels 
inside the nodes represent: majority class in that node, % of observations from the 
“control” class, % of observations from the “sarcoidosis” class, and % of total 
observations in that node. We follow the tree by evaluating the conditional on each 
branch, if TRUE go left, if FALSE go right. The class assignment in the leaf nodes can 
then be used for classification. 
 
Decision trees benefit from being highly interpretable, however they suffer from 
an inherent instability, as decision trees are very sensitive to the sample chosen. 
Addition or deletion of even a single observation could change the resulting tree, and 
thus individual trees are considered unstable. Tree ensembles, or “Forest” methods 
have been developed to improve the robustness of decision tree classifiers, including 
methods such as Bagging (Breiman, 1996), Boosting (Freund & Schapire, 1996), and 
Random Forests (Breiman, 2001).  
Bagging operates by generating bootstrapped samples (with replacement) from 
the input training data, then generating a tree for each sample. Class prediction is done 
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by majority vote across all the trees. Boosting operates by generating weighted errors 
for each constructed tree, and generating a new tree based on the residual errors from 
the previous tree to minimize the final error. Random forests operate by also generating 
bootstrapped samples (with replacement), but instead of using all the columns to 
generate individual trees like Bagging, a randomly selected subset of columns is used. 
This enables more diversity across trees compared with Bagging and tends to improve 
the final prediction accuracy by “de-correlating” the individual trees. Construction of a 
RF model follows these steps (X. Chen & Ishwaran, 2012): 
1) Sample ntree bootstrapped samples from the input data, with replacement. 
2) Grow a decision tree using the CART methodology and the Gini Index for each 
ntree sample. At each node in the tree, consider a random set of mtry columns to 
decide how to split. Grow the tree until the sample size in each node reaches a 
specified nodesize value, or until the tree can no longer be split further. 
3) Aggregate the information across all ntree nodes so that new data can be 
classified by majority vote. 
4) Compute the out-of-bag (OOB) error rate for each of the ntrees by using the data 
left out of the bootstrapped sample as test data. 
Another key advantage of forest-based approaches is that variable importance can 
be measured, and thus the algorithm can be used for feature selection. Variable 
importance is calculated by measuring how much a given variable improves the 
information gain across the trees. This importance metric is calculated by evaluating 
how much a given variable decreases the Gini Index, summed for every node where 
that variable is used in each tree and normalized by the number of trees. This 
procedure allows us to determine which variables have the most information to assist 
classification and rank their importance. As such, RF models have been used in “high-p, 
low-n” problems (high feature count, low sample count problems) such as genomic 





3.2 - Random Forest Modeling – Methodology 
 
All RF models were generated with 10-fold cross validation, repeated three times 
to reduce overfitting, using the train function in the Caret package in R. K-fold Cross 
validation is a technique which reduces overfitting by randomly separating the input data 
into k discrete partitions, then leaving one subset out of the training process to use as a 
validation set while the other k-1 partitions are used as a training set. The process is 
repeated until all k subsets have been used as the validation set, and the results of all k 
models are averaged to generate a final model. One advantage of this approach is that 
every observation is guaranteed to be used exactly once in the validation set. We 
repeated the 10-fold cross validation three times and averaged the results from all three 
iterations to further reduce overfitting and to help create a more generalizable model on 
real test data. 
 Additionally, we optimized the hyperparameter mtry (the number of columns 
randomly selected for each node in each individual decision tree). We used a range of 
five evenly spaced numbers ranging from one to the total number of columns, to try and 
find a near-optimal value of mtry in reasonable computational time. Each value of mtry 
was tested on a full RF with 10-fold cross validation repeated three times, and the 
optimal Kappa value was measured for each of the fitted models, and the optimal mtry 
was selected for use in the final model. The Kappa statistic is a modified accuracy 
statistic that also considers the expected accuracy based on random chance. Kappa 
ranges from -1 to 1, with a Kappa of 1 indicating perfect classification, Kappa of 0 
indicating accuracy exactly in line with the expected values (a perfectly random 
classifier), and a Kappa of -1 indicating a perfectly opposite classification. Optimal 








Optimal mtry values ≤0.75 ≤0.8 ≤0.85 ≤0.9 ≤0.95 
Logistic Top10 SNPs 2 2 2 2 2 
Logistic Top100 SNPs 1 3 3 1 1 
Logistic Top500 SNPs 57 65 74 85 93 
Logistic Top1000 SNPs 70 73 160 134 201 
Logistic Top2000 SNPs 92 284 205 449 505 
LASSO 484 SNPs 87 174 175 352 266 
Table 2. Optimal values for the random forest hyperparameter mtry after 10-fold cross 
validation, repeated three times. These values were generated without the use of test 
data to ensure test data remained independent from model construction. Trained 
models were created with these optimal values and applied to the test data to evaluate 
final model performance.  
 
3.3 - Random Forest Modeling – Results 
 
Each trained model was applied to the test data to evaluate model performance. 
The test data was not involved in the training or validation or hyperparameter 
optimization process, and thus represents a real-world test of the model’s 
generalizability to new data. We plotted the area under the receiving operating 
characteristic curve (AUC), which is a common metric used to evaluate model 
performance (Figure 6), as well as plotted the Kappa values (Figure 7). Each model was 
also evaluated in comparison to the “no-information model”, which is the accuracy you 
would expect if you simply always predicted the majority class. In this case, our test 
data contained 55.58% controls, which means that a no-information model would simply 
always predict that a person is a control and reach exactly 55.58% accuracy 
automatically. Therefore, we are only interested in models that can outperform this 
baseline. In this experiment, only one model statistically outperformed the no-
information model, the top500 SNP model with an r-squared cutoff of 0.9. This model 
achieved an absolute accuracy of 0.5995 (p = 0.041), a Kappa of 0.1599, a sensitivity of 












Kappa Sensitivity Specificity AUC 
Logistic Top10 - 0.95 0.5364 0.8005 0.0275 0.306 0.7205 0.5367 
Logistic Top100 – 0.95 0.5801 0.1732 0.1121 0.3169 0.7904 0.5785 
Logistic Top100 – 0.90 0.5777 0.1998 0.1044 0.3005 0.7991 0.5759 
Logistic Top100 – 0.85 0.5777 0.1998 0.1225 0.3989 0.7205 0.5827 
Logistic Top100 – 0.80 0.5631 0.4028 0.0933 0.388 0.7031 0.5843 
Logistic Top100 – 0.75 0.5607 0.4416 0.0678 0.2787 0.786 0.5827 
Logistic Top500 – 0.95 0.5752 0.2288 0.1059 0.3333 0.7686 0.5844 
Logistic Top500 – 0.90 0.5995 0.041 (*) 0.1599 0.377 0.7773 0.6019 
Logistic Top500 – 0.85 0.5898 0.0901 0.1375 0.3552 0.7773 0.5914 
Logistic Top500 – 0.80 0.5947 0.0618 0.1477 0.3607 0.7817 0.5859 
Logistic Top500 – 0.75 0.5825 0.1489 0.1217 0.3443 0.7729 0.5792 
Logistic Top1000 – 0.95 0.585 0.127 0.1152 0.2842 0.8253 0.5931 
Logistic Top1000 – 0.90 0.5825 0.1489 0.1126 0.2951 0.8122 0.5916 
Logistic Top1000 – 0.85 0.5898 0.0901 0.1246 0.2842 0.8341 0.5973 
Logistic Top1000 – 0.80 0.5874 0.1074 0.1209 0.2896 0.8253 0.6073 
Logistic Top1000 – 0.75 0.5704 0.2932 0.0767 0.2295 0.8428 0.5921 
Logistic Top2000 – 0.95 0.5631 0.4028 0.0594 0.2131 0.8428 0.5769 
Logistic Top2000 – 0.90 0.5825 0.1489 0.1012 0.235 0.8603 0.5886 
Logistic Top2000 – 0.85 0.585 0.127 0.1017 0.2131 0.8821 0.5973 
Logistic Top2000 – 0.80 0.5752 0.2288 0.0731 0.1639 0.9039 0.5983 
Logistic Top2000 – 0.75 0.5752 0.2288 0.072 0.1585 0.9083 0.5993 
LASSO – 0.95 0.5631 0.4028 0.0461 0.1475 0.8952 0.5868 
LASSO – 0.90 0.5874 0.1074 0.1044 0.2022 0.8952 0.6014 
LASSO – 0.85 0.5752 0.2288 0.0687 0.1421 0.9214 0.5952 
LASSO – 0.80 0.568 0.3283 0.06 0.1694 0.8865 0.5846 
LASSO – 0.75 0.568 0.3283 0.0567 0.153 0.8996 0.5947 
Table 3. Full results from the Random Forest models. Logistic Top500 with 0.9 cutoff 







Figure 6. Area under the ROC curve for each SNP subset across five Pearson r2 
threshold cutoffs. Each bar represents a fully trained 10-fold cross validated 3x repeated 








Figure 7. Random forest models - Kappa values for each SNP subset across five 
Pearson r2 threshold cutoffs. Star indicates that the model was significantly more 
accurate (p <0.05) compared to the no-information model. Each bar represents a fully 











3.4 - Support Vector Machine with Radial Kernel – background 
 
 After running the RF models, we wondered if we could improve the results by 
utilizing support vector machines (SVM). SVMs are a powerful class of machine 
learning algorithms that have been used successfully in genomic prediction of traits in 
plant and animal breeding, analyzing genetic subtypes of cancer, discovery of active 
epigenic regions of the genome, and prediction of coronary heart disease, chronic 
kidney disease, and diabetes, among others diseases (Harimoorthy & Thangavelu, 
2020; Huang et al., 2018; Zhang et al., 2017; Zhao et al., 2020). SVMs operate by 
drawing a hyperplane through your data to maximally separate the classes. To select an 
optimal hyperplane separator, a SVM works to maximize the distance between the 
hyperplane and the nearest datapoints. The nearest datapoints to the hyperplane are 
called the support vectors, and SVMs use the support vectors when calculating the 
class of a new observation. This technique relies on the ability to draw a linear 
hyperplane capable of separating your observations. However, for complex non-linear 
problems, a hyperplane drawn in the current problem dimension will generally not result 
in a good separator. To enable non-linear classification, SVMs have adopted the 
“Kernel Trick”, which applies a function to each observation which projects the data to a 
higher dimensional space. Good linear separations can usually be found in higher-
dimensional space, enabling the SVM to operate normally but still learn non-linear 
relationships. 
 Several kernel functions exist which can project data to a higher dimension. 
Polynomial functions, the radial-basis function, and the sigmoid function are three 
examples widely used by SVMs. In general, the radial-basis function works well on a 
variety of data types and was selected as the kernel function for use in this project. 
Each kernel has unique parameters that can be tuned to further optimize the model’s 
performance. In the case of the radial-basis kernel SVM, the hyperparameters needed 
to tune are the sigma and the soft margin cost parameter. Sigma controls how much 
influence a support vector has on determining the final class of the predicted data point. 
Lower sigma means less influence of individual support vectors, which increases the 
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variance but decreases the bias. The soft margin cost parameter, or C, controls how 
soft or hard the decision boundary is, larger values of C allow less mis-classified 
datapoints, but too hard of a decision boundary can hurt the overall generalizability of 
the model on new data. As with all hyperparameters, a range of values should be tested 
to determine the optimal values for a given problem. To optimize C and sigma for the 
SVM, we utilized the train function in the Caret package in R. We used a grid search 
with 15 total combinations of C and Sigma and ran 10-fold cross validation with 3x 
repeats to find the optimal combination of parameters (Table 4). 
 
Optimal sigma and C 
 values 
≤0.75 ≤0.8 ≤0.85 ≤0.9 ≤0.95 
Logistic Top100 SNPs (0.069, 
0.5) 
(0.056, 8) (0.056, 8) (0.045, 8) (0.040, 2) 










Logistic Top1000 SNPs (0.003, 
0.25) 
(0.003, 1) (0.003, 1) (0.002, 1) (0.002, 1) 



















Table 4. Optimal values for the SVM radial kernel hyperparameter sigma and C after 
10-fold cross validation, repeated 3x. These values were generated without the use of 
test data to ensure test data remained independent from model construction. Trained 
models were created with these optimal values and applied to the test data to evaluate 
final model performance.  
 
 
3.5 - Support Vector Machine – Results 
 As with RF, we plotted both the AUC (Figure 8) and the Kappa value (Figure 9) 
for each model to visually inspect relative quality. In general, we saw an increase in 
performance up to the Top1000 models which performed the best. Performance then 
decreased at the Top2000 model and the LASSO model, both of which contain many 
more features. We found that SVM utilizing the top1000 SNP 0.75 r2 model 
outperformed the best RF model in terms of absolute accuracy, achieving accuracy of 
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0.6068 (p = 0.0207), kappa of 0.1858, sensitivity of 0.4484, specificity of 0.7336, and an 
AUC of 0.6016.  Full results, including accuracy, Accuracy p-value, Kappa, sensitivity, 
specificity, and AUC, are available for each model (Table 5). 
 






Kappa Sensitivity Specificity AUC 
Logistic Top100 – 0.95 0.5874 0.1074 0.125 0.3115 0.8079 0.5885 
Logistic Top100 – 0.90 0.551 0.5985 0.0526 0.2951 0.7555 0.58 
Logistic Top100 – 0.85 0.5558 0.5205 0.0597 0.2842 0.7729 0.5775 
Logistic Top100 – 0.80 0.5607 0.4416 0.0646 0.2623 0.7991 0.5799 
Logistic Top100 – 0.75 0.5704 0.2932 0.0905 0.3005 0.786 0.564 
Logistic Top500 – 0.95 0.5801 0.1732 0.1261 0.3934 0.7293 0.5823 
Logistic Top500 – 0.90 0.5752 0.2288 0.118 0.3989 0.7162 0.5928 
Logistic Top500 – 0.85 0.5777 0.1998 0.1235 0.4044 0.7162 0.59 
Logistic Top500 – 0.80 0.5801 0.1732 0.129 0.4098 0.7162 0.5904 
Logistic Top500 – 0.75 0.5558 0.5205 0.0777 0.377 0.6987 0.5724 
Logistic Top1000 – 0.95 0.6044 0.0262 (*) 0.1766 0.4208 0.7511 0.5877 
Logistic Top1000 – 0.90 0.6044 0.0262 (*) 0.1785 0.4317 0.7424 0.5885 
Logistic Top1000 – 0.85 0.5922 0.0749 0.1518 0.4098 0.738 0.5884 
Logistic Top1000 – 0.80 0.5801 0.1732 0.129 0.4098 0.7162 0.5917 
Logistic Top1000 – 0.75 0.6068 0.0207 (*) 0.1858 0.4481 0.7336 0.6016 
Logistic Top2000 – 0.95 0.551 0.5985 0.0676 0.3716 0.6943 0.5629 
Logistic Top2000 – 0.90 0.5461 0.6728 0.0628 0.3934 0.6681 0.5643 
Logistic Top2000 – 0.85 0.5437 0.7077 0.0562 0.3825 0.6725 0.5645 
Logistic Top2000 – 0.80 0.5485 0.6363 0.0673 0.3934 0.6725 0.5722 
Logistic Top2000 – 0.75 0.5388 0.7717 0.0461 0.377 0.6681 0.5701 
LASSO – 0.95 0.534 0.8269 0.0489 0.4372 0.6114 0.5625 
LASSO – 0.90 0.5267 0.8922 0.0335 0.4262 0.607 0.5613 
LASSO – 0.85 0.5267 0.8922 0.0335 0.4262 0.607 0.5605 
LASSO – 0.80 0.5364 0.8005 0.0544 0.4426 0.6114 0.5619 
LASSO – 0.75 0.5316 0.8511 0.0434 0.4317 0.6114 0.5615 
Table 5. Full results from the SVM models. Logistic Top1000 with 0.95 and 0.90 cutoff 
(p=0.0262), as well as Top1000 with 0.75 cutoff  (p=0.0207) achieved significant 





Figure 8. Support vector machine models - Area under the ROC curve for each SNP 
subset across five Pearson r2 threshold cutoffs. Each bar represents a fully trained 10-






Figure 9. Support vector machine models - Kappa values for each SNP subset across 
five Pearson r2 threshold cutoffs. Star indicates that the model was significantly more 
accurate (p <0.05) compared to the no-information model. Each bar represents a fully 
trained 10-fold cross validated repeated three times random forest model. 
 
 
3.6 - Neural Network modeling – background 
 
 After SVM modeling showed some improvement compared to RF, we wondered 
if we could gain even more performance by utilizing neural networks (NNs). NNs have 
become increasingly popular supervised machine learning tools, in part due to their 
ability to flexibly learn non-linear functions, and have widespread use and applications 
in many domains, including disease prediction. At the most basic level, a NN is a 
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directed graph with weighted edges which convert raw input with n-dimensional features 
into a single-valued outcome, usually a probability of that observation belonging to a 
particular class. The basic until of many NNs is the sigmoid neuron, which converts a 
vector of input values (multiplied by their respective weights) into a (0,1) interval. If the 
sigmoid neuron is the final neuron in the network, the output value represents the 
probability of that observation belonging to a given class. For the model to learn, we 
must supply class labels for each observation in the training set and evaluate the 
accuracy of the final output based on an evaluation function. If the output does not 
match the class label, we must update the weights to minimize the evaluation function’s 
error through a process known as back-propagation. Usually, back-propagation is 
achieved with a process known as gradient descent. Gradient descent is a non-linear 
optimization technique which calculates the derivative of the evaluation function with 
respect to the weights and updates the weights to lower the overall error (the function 
takes a step “downhill” to reach a lower error value). This process of backpropagation is 
repeated until weights are stabilized (they have reached convergence at the local 
minima), or until a set number of backpropagation cycles have occurred (known as 
early-stopping).  
A single-layer NN is one in which input features are directly connected to the 
output neuron. A network of this type is only capable of learning direct linear 
relationships. To increase the flexibility of NNs, multi-layer networks have been 
developed which include the addition of one or more layers of “hidden neurons”, which 
are intermediate sigmoid neurons. The addition of a hidden layer(s) enables the model 
to flexibly learn non-linear functions. In general, the more hidden layers you add, the 
more abstract the function is you can learn. However special consideration must be 
made to preserve the gradient across deep networks, which is known to rapidly deplete 
(known as the vanishing gradient problem). Recent advances in the field have helped to 
alleviate this issue, enabling many-layer networks (known as deep learning) to become 
useful and powerful techniques for learning solutions to very complex problems, like 
how to select winning moves in the board games Go and Chess (Silver et al., 2018), or 
how to drive a car in full self-driving vehicles (Autopilot AI - Tesla, 2021). However, deep 
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learning NNs generally require and greatly benefit from large volumes of training 
examples to accurately learn their very abstract functions. 
In this work, we applied a multi-layer NN with sigmoid neurons and a single 
hidden layer to our training data, using the nnet package in R. An example of the 
network architecture on the Top100 0.9 r2 model is shown (Figure 10).  The 
hyperparameters we were able to optimize were size and decay. Size is the number of 
neurons in the hidden layer. Decay is an additional parameter used to control how large 
the weights can become, which can help avoid overfitting your model by preventing a 
few very large weights dominate the model. Specifically, decay multiplied by the L2 
norm of all the weights is added to the evaluation function at each iteration of 
backpropagation, which effectively keeps the weights at a small size. A grid of 
hyperparameters was tested, using size = 1, 3, or 5, and decay = 0, 0.01, 0.1, 0.2, and 
0.5. The size of the hidden layer was kept small to reduce computation time. A table 





Figure 10. Single hidden layer neural network architecture for the Top100 0.9 r2 cutoff 
model (16 SNPs + Sex used as features).  
 
Optimal size and decay values ≤0.75 ≤0.8 ≤0.85 ≤0.9 ≤0.95 
Logistic Top10 SNPs (1, 0.5) (1, 0.5) (1, 0.5) (1, 0.5) (1, 0.5) 
Logistic Top100 SNPs (1, 0.00) (1, 0.01) (3, 0.1) (5, 0.5) (5, 0.5) 
Logistic Top500 SNPs (1, 0.5) (1, 0.1) (1, 0.2) (1, 0.1) (1, 0.1) 
Logistic Top1000 SNPs (1, 0.5) (1, 0.5) (1, 0.5) (1, 0.5) (1, 0.5) 
Logistic Top2000 SNPs (5, 0.5) (5, 0.5) (5, 0.00) (5, 0.5) (5, 0.5) 
LASSO 484 SNPs (5, 0.5) (5, 0.5) (5, 0.5) (5, 0.5) (5, 0.5) 
Table 6. Optimal values for the neural network hyperparameters size and decay after 
10-fold cross validation, repeated three times. These values were generated without the 
use of test data to ensure test data remained independent from model construction. 
Trained models were created with these optimal values and applied to the test data to 




3.6 - Neural Network modeling – results 
 
As with RF and SVM, we recorded the full results for each model (Table 7) as 
well as plotted the AUC (Figure 11) and the Kappa value (Figure 12) to visually inspect 
the quality of each model. No models achieved significantly better accuracy compared 
with the naïve model; however, the Top100 0.85 and Top100 0.80 models came very 
close, achieving accuracies of 0.5971 (p = 0.051). The top100 0.85 model had a Kappa 
of 0.1657, AUC of 0.6103, sensitivity of 0.4372, and specificity of 0.7249, while the 
top100 0.8 model had a Kappa of 0.1759, AUC of 0.6042, sensitivity of 0.4973, and 
specificity of 0.6769. Overall performance of the NNs tended to decrease as the feature 
space grew. One possible reason for this decrease could be that the hidden layer was 
too small relative to the number of features, which limited the total number of 
interactions that could be modeled which in turn hurt performance. We would like to 






















Kappa Sensitivity Specificity AUC 
Logistic Top10 – 0.95 0.5485 0.6363 0.0348 0.2295 0.8035 0.5375 
Logistic Top100 – 0.95 0.5825 0.1489 0.1277 0.377 0.7467 0.5957 
Logistic Top100 – 0.90 0.5922 0.0749 0.1441 0.3661 0.7729 0.5938 
Logistic Top100 – 0.85 0.5971 0.0505 0.1657 0.4372 0.7249 0.6103 
Logistic Top100 – 0.80 0.5971 0.0505 0.1759 0.4973 0.6769 0.6042 
Logistic Top100 – 0.75 0.5874 0.1074 0.1504 0.4536 0.6943 0.5986 
Logistic Top500 – 0.95 0.5316 0.8511 0.0528 0.4809 0.5721 0.5545 
Logistic Top500 – 0.90 0.5267 0.8922 0.0388 0.4536 0.5852 0.5564 
Logistic Top500 – 0.85 0.5583 0.481 0.0822 0.377 0.7031 0.5627 
Logistic Top500 – 0.80 0.5485 0.6363 0.0735 0.4262 0.6463 0.5674 
Logistic Top500 – 0.75 0.5485 0.6363 0.0662 0.388 0.6769 0.5609 
Logistic Top1000 – 0.95 0.5655 0.3649 0.1039 0.4208 0.6812 0.574 
Logistic Top1000 – 0.90 0.5752 0.2288 0.1249 0.4372 0.6856 0.5792 
Logistic Top1000 – 0.85 0.5947 0.0618 0.1611 0.4372 0.7205 0.5819 
Logistic Top1000 – 0.80 0.5655 0.3649 0.1029 0.4153 0.6856 0.5892 
Logistic Top1000 – 0.75 0.5752 0.2288 0.1219 0.4208 0.6987 0.5855 
Logistic Top2000 – 0.95 0.5485 0.6363 0.0735 0.4262 0.6463 0.5635 
Logistic Top2000 – 0.90 0.5413 0.7407 0.057 0.4098 0.6463 0.5423 
Logistic Top2000 – 0.85 0.5558 0.5205 0.0777 0.377 0.6987 0.5576 
Logistic Top2000 – 0.80 0.5631 0.4028 0.0943 0.3934 0.6987 0.5774 
Logistic Top2000 – 0.75 0.5461 0.6728 0.0607 0.3825 0.6769 0.5539 
LASSO – 0.95 0.5461 0.6728 0.0731 0.4481 0.6245 0.5513 
LASSO – 0.90 0.5437 0.7077 0.0635 0.4208 0.6419 0.544 
LASSO – 0.85 0.5558 0.5205 0.095 0.4699 0.6245 0.5465 
LASSO – 0.80 0.5607 0.4416 0.1029 0.4645 0.6376 0.5628 
LASSO – 0.75 0.5461 0.6728 0.0721 0.4426 0.6288 0.5517 
Table 7. Full results from the neural network models. No models achieved significant 
improvement  p< 0.05 over the no information model, however Logistic Top100 with 
0.85 and 0.80 cutoff were very close with p=0.0505. Despite this, the AUC was quite 





Figure 11. Neural network models - Area under the ROC curve for each SNP subset 
across five Pearson r2 threshold cutoffs. Each bar represents a fully trained 10-fold 





Figure 12. Neural network models - Kappa values for each SNP subset across five 
Pearson r2 threshold cutoffs. Each bar represents a fully trained 10-fold cross validated 











Chapter 4 – Functional Score Assignment and 
Modeling 
 
4.1 Functional Score Assignment – CADD and FATHMM-XF 
 
 We then determined if blending the logistic regression feature selection with a 
measurement of the likelihood of a SNP to contribute to disease would improve 
modeling performance. We chose CADD scores and FATHMM-XF scores for this task, 
in part because they are both available for most of the SNPs in the GRCh38 genome 
assembly, allowing annotation of most SNPs. Both resources also have online tools 
(https://cadd-staging.kircherlab.bihealth.org/score and 
http://fathmm.biocompute.org.uk/fathmm-xf/) which enable a user to simply upload a list 
of SNPs and download the relevant scores.  
 For CADD scores, we first filtered out poorly correlate SNPs by sorting the 
logistic regression results by p-value and extracting all SNPs with p < 0.05. With this 
subset of 429,870 SNPs, we used the SNP ID to extract CADD scores and obtained 
80.5% of SNPs (346,384 / 429,870) with labeled CADD scores. All FATHMM scores 
were downloaded from the website and merged with all the logistic regression SNPs. A 
total of 92.57% of SNPs (7,149,617 / 7,723,468) had labeled FATHMM-XF scores. 
91.3% of these SNPs (316,276 / 346,384) had both CADD and FATHMM-XF scores. 
Figure 13 shows the density of FATHMM-XF and CADD scores for all 316,276 of these 
SNPs. Most have very low functional scores, which is to be expected since most SNPs 
in the genome have low functional scores. 
We then merged the CADD scores or the FATHMM-XF scores with the logistic 
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This formulation allows us to adjust the proportion of p-value contributing to the overall 
score versus the proportion of functional score. As c increases, the contribution of the p-
value to the overall score decreases. As c approaches 1, the contribution of the p-value 
to the overall score becomes increasingly large. For all initial experiments, the value of c 
was set to 2. 
It should be noted that the CADD scores range from 0 to 99 based on their 
pathogenicity rank relative to all other possible 8.6 billion substitutions in the human 
genome, while the FATHMM-XF scores range from 0 to 1. In practice, this difference in 
potential values meant that in all initial experiments, the relative contribution from the 
logistic p-value was higher for the fathmm_logistic scores compared to the cadd_logistic 
scores (Figure 14). Future experiments could correct this issue by increasing the log 





Figure 13. Density plot of the distribution of CADD and FATHMM scores across all 
316,276 SNPs with both scores in common. CADD scores were normalized to fit within 






Figure 14. Density plot of the distribution of CADD and FATHMM scores across the top 
10,000 SNPs based on the top blended functional scores. 1,375 SNPs were found in 
both subsets. CADD scores were normalized to fit within a 0 to 1 range. It is clear we 
are enriching for higher CADD score SNPs, but not enriching as much for higher 
FATHMM-XF score SNPs. 
 
4.2 CADD + Logistic blended results – Random Forest, SVM, and Neural 
Network 
 
 The top 10, 100, 500, 1000, and 1000 SNPs based on the cadd_logistic blended 
score was extracted and modeled with RF, SVM, and NN as before. To reduce the total 
computation time, a single Pearson’s r2 correlation cutoff of 0.9 was used for these 
experiments, with a slight difference in the method used for SNP removal. Previously, if 
a pair of SNPs had a correlation coefficient above the threshold, the SNP with the 
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higher mean correlation across all columns was selected for removal. This is an 
appropriate strategy when the two SNPs are otherwise equal. However, SNPs can have 
variable functional scores even when they are otherwise correlated, and we are 
interested in testing the hypothesis that adding functional scores improves predictive 
performance. Therefore, when a pair of SNPs has a correlation cutoff above the 
threshold, we would like to keep the SNP with the higher functional score. The total 
number of SNPs retained in the cadd_logistic models are summarized in Table 8. The 
number of retained SNPs is significantly higher than in the no-functional score models 
used in Chapter 3. This is an indication that there are fewer correlated variables in the 
top SNPs because the functional score component of the blended score is boosting the 
rank of uncorrelated lower p-value SNPs.    
 
Number of SNPs retained 
CADD + Logistic 
≤ 0.9 r2 
Top10 SNPs 9 
Top100 SNPs 76 
Top500 SNPs 405 
Top1000 SNPs 832 
Top2000 SNPs 1677 
Table 8.  Number of SNPs retained after filtering correlated variables for the CADD + 
logistic blended models. There are significantly more SNPs retained after correlation 
filtering compared to the baseline no-functional score models. 
 
 The models were run as before, optimizing hyperparameters using 10-fold 3x 
repeated cross validation on the training data before applying the optimal model / 
hyperparameters to the test data. Hyperparameter optimization is summarized in Table 
9. Full results for all models are reported in Table 10. AUC measurements are plotted in 
Figure 15, and Kappa measurements are plotted in Figure 16. No models achieved 
significantly better performance compared to the naïve model. In general, the 
performance on average tended to worsen with this strategy over simply using the most 




Optimal hyperparameters NNET –  
size and decay 
RF –  
mtry 
SVM – 
sigma and C 
cadd_logistic Top10 (3, 0.5) 3 (0.075, 0.25) 
cadd_logistic Top100 (5, 0) 47 (0.007, 0.25) 
cadd_logistic Top500 (5, 0.5) 163 (0.001, 0.5) 
cadd_logistic Top1000 (5, 0.1) 501 (0.001, 0.5) 
cadd_logistic Top2000 (5, 0.2) 1008 (0.0003, 0.5) 




CADD + Logistic 
Results 
Accuracy Accuracy > 
Null Accuracy? 
(P-value) 
Kappa Sensitivity Specificity AUC 
RF – Top10 0.9 0.5825 0.1489 0.1197 0.3333 0.7817 0.5781 
RF – Top100 0.9 0.5583 0.481 0.0707 0.3169 0.7511 0.591 
RF – Top500 0.9 0.5825 0.1489 0.1147 0.306 0.8035 0.5859 
RF – Top1000 0.9 0.5898 0.0901 0.1185 0.2514 0.8603 0.6005 
RF – Top2000 0.9 0.5898 0.0901 0.1112 0.2131 0.8908 0.6027 
NNET – Top10 0.9 0.5583 0.481 0.0512 0.2186 0.8297 0.4504 
NNET – Top100 0.9 0.5825 0.1489 0.1461 0.4809 0.6638 0.5807 
NNET – Top500 0.9 0.5607 0.4416 0.1233 0.5792 0.5459 0.5683 
NNET – Top1000 0.9 0.5437 0.7077 0.0718 0.4645 0.607 0.5409 
NNET – Top2000 0.9 0.551 0.5985 0.081 0.4426 0.6376 0.5404 
SVM – Top10 0.9 0.5777 0.1998 0.0982 0.2678 0.8253 0.566 
SVM – Top100 0.9 0.5631 0.4028 0.1034 0.4426 0.6594 0.5921 
SVM – Top500 0.9 0.5631 0.4028 0.1103 0.4809 0.6288 0.57 
SVM – Top1000 0.9 0.5437 0.7077 0.0759 0.4863 0.5895 0.5874 
SVM – Top2000 0.9 0.5728 0.26 0.1272 0.4754 0.6507 0.5996 
Table 10.  Full results table for the cadd_logistic blended models. No models were 






Figure 15.  AUC values for all cadd_logistic models. In general, we see lower AUC 






Figure 16.  Kappa values for all cadd_logistic models. No models were significantly 













4.3 FATHMM-XF results – Random Forest, SVM, and Neural Network 
 
 Modeling with RF, NNET, and SVM was repeated for the fathmm_logistic 
blended score top10, top 100, top500, top1000, and top2000 SNPs, again using a 
single 0.9 r2 correlation cutoff threshold and keeping the SNP with the higher functional 
score when choosing which SNP to keep. The number of SNPs retained was similar to 
those seen in the no-functional score models (Table 11), indicating that the balance of 
the fathmm_logistic score is too heavily in favor of the logistic p-value.  
 
Number of SNPs retained 
FATHMM-XF + Logistic 
≤ 0.9 r2 
Top10 SNPs 1 
Top100 SNPs 15 
Top500 SNPs 103 
Top1000 SNPs 213 
Top2000 SNPs 528 
Table 11.  Number of SNPs retained after filtering correlated variables for the 
fathmm_logistic blended models. 
 
Hyperparameter optimization was conducted as before, with 10-fold cross 
validation repeated three times across a grid of hyperparameters and is summarized 
(Table 12), full fathmm_logistic results are reported (Table 13), and AUC values are 
plotted (Figure 17), as well as Kappa values (Figure 18). One model, top500 RF, 
achieved significance (p=0.026) compared with the naïve model, and achieved 0.6044 







Optimal hyperparameters NNET –  
size and decay 
RF –  
mtry 
SVM – 
sigma and C 
fathmm_logistic Top10 (1, 0.5) 2 (0.301, 256) 
fathmm_logistic Top100 (5, 0) 1 (0.046, 0.5) 
fathmm_logistic Top500 (5, 0.2) 64 (0.005, 0.5) 
fathmm_logistic Top1000 (5, 0.2) 87 (0.002, 1.0) 
fathmm_logistic Top2000 (5, 0.5) 425 (0.0001, 0.5) 




FATHMM + Logistic 
Results 
Accuracy Accuracy > 
Null Accuracy? 
(P-value) 
Kappa Sensitivity Specificity AUC 
RF – Top10 0.9 0.5534 0.5598 0.0452 0.235 0.8079 0.5364 
RF – Top100 0.9 0.5801 0.1732 0.1171 0.3443 0.7686 0.5783 
RF – Top500 0.9 0.6044 0.0262 (*) 0.1663 0.3607 0.7991 0.5966 
RF – Top1000 0.9 0.5631 0.4028 0.0692 0.2623 0.8035 0.5866 
RF – Top2000 0.9 0.5898 0.0901 0.1154 0.235 0.8734 0.5931 
NNET – Top10 0.9 0.5534 0.5598 0.0452 0.235 0.8079 0.5378 
NNET – Top100 0.9 0.551 0.5985 0.0655 0.3607 0.7031 0.5529 
NNET – Top500 0.9 0.5291 0.8728 0.0411 0.4426 0.5983 0.5649 
NNET – Top1000 0.9 0.5461 0.6728 0.0543 0.3497 0.7031 0.5563 
NNET – Top2000 0.9 0.5583 0.481 0.0811 0.3716 0.7074 0.5619 
SVM – Top10 0.9 0.5558 0.5205 0 0 1 0.5209 
SVM – Top100 0.9 0.5655 0.3649 0.076 0.2732 0.7991 0.5777 
SVM – Top500 0.9 0.585 0.127 0.1372 0.4044 0.7293 0.5931 
SVM – Top1000 0.9 0.5801 0.1732 0.132 0.4262 0.7031 0.5972 
SVM – Top2000 0.9 0.5898 0.0901 0.1482 0.4153 0.7293 0.5773 
Table 13.  Full results table for the fathmm_logistic blended models. The Top500 RF 






Figure 17.  AUC values for all fathmm_logistic models. No models achieved > 0.6 AUC. 










Figure 18. Kappa values for all fathmm_logistic models. The top500 RF model was 











Chapter 5 – Conclusions and Future Directions 
  
5.1 – Conclusions 
 
Here we have shown that sarcoidosis disease incidence in African Americans 
can be successfully modeled with various supervised machine learning techniques such 
as RF, SVM, and NN. We have generated multiple models that significantly outperform 
a naïve model in terms of absolute accuracy on test samples. The best model in terms 
of absolute accuracy and Kappa was the SVM Top1000 0.75 no-functional score model, 
with an accuracy of 0.6068 and a Kappa of 0.1858. The best model in terms of AUC 
was the NN Top100 0.75 with a 0.6103 AUC. 
The top performing models were able to classify sarcoidosis cases with a 
sensitivity of 0.437 to 0.448, which are in-line with the expected theoretical heritability of 
40-66% published in the literature for Scandinavian populations. While heritability for 
diseases can differ greatly between populations, these results support the idea that this 
estimate is plausible for African Americans with sarcoidosis. 
The question then becomes, are we near the theoretical limit of predictive power 
using a genetics-only approach for a disease with an estimated 40-66% heritability or 
would more powerful machine learning techniques such as deep learning improve 
predictive accuracy further? Would increasing the sample size of the training or test sets 
result in a subsequent  improvement to accuracy? Answers to these questions could 
help further establish the heritability estimate for sarcoidosis in African Americans as 
well as be of clinical utility. 
Functional score incorporation with CADD and FATHMM-XF does not seem to 
improve predictive power. However, some SNPs with high functional scores and 
reasonable logistic regression p-values may still contain important clues about the 
mechanism of sarcoidosis granuloma formation. Further experimentation with these 




5.2 – Future Directions  
 
 We can envision several next steps for this project, both short-term and longer 
term. Most pressingly in the short term is the need to adjust log base c in the 
fathmm_logistic calculation so that functional score will take a higher proportion of the 
blended score. Additionally, we could consider running the functional score models with 
all the Pearson r2 cutoffs used in the non-functional score section to further improve 
robustness of the results. Next, we need to increase the maximum size in the NN 
hyperparameter search grid, which could result in significant improvements to those 
models.  
 We would additionally like to employ deep learning to help identify more complex 
structure in the data and potentially improve prediction accuracy. Further, we are 
interested in consolidating the individual SNPs into their respective haplotype blocks, so 
that more information is contained within a single feature. We are also interested in 
comparing our predictive modeling results with previously established statistical 
methods which use polygenic risk scores to predict disease incidence, such as best 
linear unbiased prediction (BLUP), BayesA, and LDPred (Clark & Van Der Werf, 2013; 
Meuwissen et al., 2001; Vilhjálmsson et al., 2015). Finally, we plan to apply alternative 
feature selection algorithms beyond logistic regression and LASSO to the entire list of  
~7.7 million SNPs, to see if alternate methods can yield SNPs which are even more 
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